Kinder Morgan (KMI) Advances While Market Declines: Some Information for Investors

CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission

Smith Micro expects Q3 2026 revenue of $5.0M-$5.4M as SafePath launches move into Q3

TSS maintains full-year adjusted EBITDA outlook toward upper end of $20M-$22M range as $17M Vera Rubin buildout nears September completion

Genasys signals fiscal 2026 record year outlook as it expects to complete initial $9M CROWS delivery within the year